Eugenia Gianos

Corrigendum to “Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Obesity Pillars 15 (2025) 100181]

Obesity Pillars 2026cited by 0position: middledoi

Corrigendum to Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Am J Clin Nutr 2025; 122: 344–367]

American Journal of Clinical Nutrition 2026cited by 0position: middledoi

Nutritional priorities to support <scp>GLP</scp>‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

Obesity 2025cited by 73position: middledoi

Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society

American Journal of Clinical Nutrition 2025cited by 64position: middledoi

Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society

Obesity Pillars 2025cited by 19position: middledoi

Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society

Obesity Pillars 2025cited by 12position: middledoi

Abstract 4366576: Treatment Implications of LDL-Cholesterol and Apolipoprotein B Discordance: Insights from the Very Large Database of Lipids (VLDbL) and the National Health and Examination Survey (NHANES)

Circulation 2025cited by 0position: middledoi

Dyslipidemia management in women of reproductive potential: An Expert Clinical Consensus from the National Lipid Association

Journal of clinical lipidology 2024cited by 46position: middledoi

Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults

American Journal of Preventive Cardiology 2024cited by 4position: middledoi

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

JAMA Internal Medicine 2021cited by 486position: middledoi

Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels

JAMA Network Open 2021cited by 116position: middledoi

Oral health and atherosclerotic cardiovascular disease: A review

American Journal of Preventive Cardiology 2021cited by 48position: firstdoi

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials

The American Journal of Medicine 2017cited by 179position: middledoi

Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction

Coronary Artery Disease 2017cited by 57position: middledoi

Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis

International Journal of Cardiology 2016cited by 45position: middledoi

A Current Approach to Statin Intolerance

Clinical Pharmacology & Therapeutics 2014cited by 17position: middledoi

Recent publications

Grants

Frequent collaborators